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Summary 
The early stages of lymphoid cell formation were stud- 
ied by testing the differentiative potential of phenotyp- 
ically defined subsets of CD34+ bone marrow cells. A 
subpopulation of CD34+ Lin- CD45RA+ cells express- 
ing CD10 was Isolated by flow cytometry. Such cells 
are CD38+, HLA-DR+ , do not express significant levels 
of Thy-l and c-kit, lacketythroid, myeloid, megakaryo- 
cytic potential, and give rise only to lymphoid T, B, 
natural killer (NK), and dendrltic cells (DC) in kinetics 
and titration experiments. Limiting dilution analysis 
demonstrates the existence of multipotential BINKIDC 
progenitor clones in the CD34h’ LinCDlO+ adult bone 
marrow cell population. Thus, nonprimitive progeni- 
tors for lymphoid cells and for DCs can be distinct from 
those of myeloid, megakaryocytic, and erythrold cells, 
implying that the DC lineage is developmentally more 
closely related to the lymphoid lineage than to the my- 
eloid lineage. This study provides new insights into 
the organization and development of the human 
lympho-hematopoietic system. 
Introduction 
Avery small proportionof hematopoietic cells(around 1%) 
in normal human hematopoietic tissues expresses the 
CD34 cell surface antigen and represents a functionally 
heterogeneous population of cells including hematopoi- 
etic stem cells (HSCs) and progenitor cells of all hemato- 
poietic lineages. The differentiation of CD34’ cells is ac- 
companied by irreversible lineage commitment and the 
production of mature CD34- hematopoietic cells of all he- 
matopoietic lineages, such as lymphoid T, natural killer 
(NK) and B cells, myeloid monocytes and granulocytes, 
erythroid cells and megakaryocyteslthrombocytes (re- 
viewed by Visser, 1992; Civin and Gore, 1993). Hemato- 
poietic lineage commitment occurs after differentiation of 
pluripotent HSCs and presumably takes place within the 
CD34+ cell compartment, since normal bi- or multipotential 
CD34- hematopoietic cells have not been described. The 
hierarchy and developmental organization of CD34+ he- 
matopoietic progenitor cells has remained relatively un- 
characterized. In particular, little is known about the early 
developmental stages for the production of lymphoid cells 
and little information is available on the relationship be- 
tween lymphoid progenitor cells and HSCs or progenitor 
cells of other lineages. Recently, we described a subset 
of adult bone marrow (ABM) CD34’ cells expressing the 
cell surface CD45RA molecule (the high molecular weight 
isoform of the protein tyrosine phosphatase CD45) but 
devoid of the lineage-specific cell surface mark& 3 (Lin 
cells) CD2, CD4, CDE, CD14, CD19, CD20, CD16, CD56, 
and glycophorin A (Galy et al., 1995). This panel of lineage 
markers collectively identifies mature and committed pre- 
cursors for T, B, NK, myeloid, and erythroid cells (Loken 
et al. 1992). Such CD34’ Lin- CD45RA’ cells are distinct 
from HSCs on the basis of their phenotype, in vitro differ- 
entiative capacity, and their ability to reconstitute hemato- 
poiesis in ectopic human fetal bone implants in surrogate 
immunodeficient C.Bl7 scidlscid (SCID) mice. This cell 
population represents an oligopotent progenitor cell pool 
devoid of long-term hematopoietic repopulating ability, ca- 
pable of producing lymphoid and myeloid but not erythroid 
cells. In spite of a considerable ability to produce myeloid 
cells, CD34+ Lin- CD45RA’ cells are more fit to generate 
lymphoid T cells (Galy et al., 1995) and NK cells (unpub- 
lished data) than the CD34’ Lin- CD45RA- population. 
These observations suggested that, perhaps, CD34’ Lin- 
CD45RA’ cells could be further fractionated to disassoci- 
ate lymphoid from myeloid progenitor cells. The existence 
in bone marrow of a CD34+ lymphoid-restricted progenitor 
cell or of a common CD34’ precursor cell of the B and T 
lineages has been postulated previously (Gore et al., 
1991) but no functional data defined such a class of pro- 
genitor cells. In the murine thymus, the most immature T 
cell precursors also generate NK, B cells, and dendritic 
cells (DCs) (Ardavin et al., 1993; Matsuzaki et al., 1993; 
Wu et al., 1991) with little or no myeloid potential, as shown 
by lack of long-term marrow repopulating ability and of 
in vitro or in vivo colony-forming ability. A functionally or 
phenotypically equivalent cell population remains to be 
characterized at the prethymic stages such as in bone 
marrow. In this study, we report the existence in normal 
human adult and fetal bone marrow, of a novel CD34’ 
progenitor cell devoid of myeloid, erythroid, and mega- 
karyocytic potential but with the ability to produce lymphoid 
cells and DCs. Furthermore, we demonstrate that multipo- 
tential B-NK lymphoid and DC progenitor clones exist 
within that population. 
Results 
Phenotypic Analysis 
A neutral endopeptidase, CD10 or CALLA, is expressed 
by some hematopoietic cells, particularly by precursors of 
T cells (thymocytes) and B cells (LeBien and McCormack, 
1989). A subset of CD34’ Lin- CD45RA’ ABM cells ex- 
presses CDlO. Such cells were isolated by flow cytometry 
sorting as CD34’ Lin- CDlO’ cells and were found to ex- 
press CD45RA, CD38, HLA-DR homogeneously with very 
low to undetectable levels of Thy-l (Table l), confirming 
that they reside within the previously characterized CD34’ 
Lin- CD45RA’ progenitor population (Galy et al., 1995). 
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Table 1. Phenotypic Characterization of CD34’ Lin- CDIO’ ABM 
Cells 
Cell surface Expression of CD34’ Lin- CD1O+cellsb 
antigen” Percent + SD (n) 
CD45RA 100 f 0 (2) 
CD36 97 k 3 (2) 
HLA-DR 99 k 1 (2) 
Thy-l 11 f 9 (3) 
c-Kit 1 + 1 (2) 
CD7 12 & 4 (2) 
CD5 1 & 2(3) 
CD25 0 + 0 (3) 
a Phenotypic analysis was performed on CD34’ Lin- cells isolated by 
flow cytometry to >96% sort purity. Sorted cells were stained with 
fluorescein or PE-conjugated MAbs anti-CD45RA, CD36, HLA-DR, 
CD7, CD5, CD25 (Becton Dickinson) and MAbs anti-CD10 conjugated 
to fluorescein (Becton Dickinson) or PE (Amac). MAbs to Thy-l (clone 
GM201) and c-kit (Amac) were used in an indirect method with isotype- 
specific PE-labeled secondary reagents and appropriate blocking. 
’ Lin = CD2, CD4, CD6, CD16, CD56, CD19, CD20, CD14, glycopho- 
rin A. Results are expressed as percent of cells positive after subtrac- 
tion of background staining with lgG1 plus IgGPa control (for direct 
staining) and IgGl plus IgM (for indirect staining) f standard deviation 
(SD) and the number of experiments is indicated in parenthesis. 
The most immature pro-6 cells express CD34 and CD10 
but lack other I3 cell lineage-associated antigens, includ- 
ing CD1 9 (Uckun, 1990), and may therefore be included in 
ourCD34+Lin- CD1 O’ABM cell population. Other CD34’ B 
cell precursors expressing CD19, CD20, or both are by 
definition excluded byvirtueof lineage marker expression. 
Molecules found on immature T cells such as CD7, CD5, 
and CD25 were not significantly expressed on CD34+ Lin- 
CD1 0’ ABM cells and the c-kit receptor was not detectable 
by immunofluorescence on CD34’ Lit--CDlO+ cells (Table 
1) (approximately 10% of CD7’ cells or of Thy-l+ cells 
were shifted at low levels above the isotype background 
level). A variety of hematopoietic assays were used to de- 
termine the differentiative capacity of this CD34’ Lin- 
CDlO’ cell population, which constitutes 5.9% + 3.7% 
(n = 13) of CD34+ Lin- ABM cells (with the CDlO-fluores- 
cein isothiocyanate monoclonal antibody [MAb] reagent 
used) and approximately 0.09% of ABM mononuclear 
cells isolated by Ficoll gradient centrifugation. 
T Cell Differentiation Potential 
T cell differentiation via thymocyte stages was observed 
within 4 to 6 weeks following microinjection of CD34’ Lit-- 
CDlO’ ABM cells into allogeneic fetal thymic grafts subse- 
quently implanted under the kidney capsule of SCID mice 
as previously described (Galy et al., 1994) (Table 2). One 
representative thymus graft out of the 16 reconstituted 
demonstrates the presence of donor-derived thymocytes, 
principally (>60% of cells) coexpressing CD4 and CD6 
with high levels of CD1 a and displaying low to high levels of 
CD3 on the cell surface, indicating ongoing thymopoiesis 
(Galy et al., 1993; Terstappen et al., 1992) (Figure 1). The 
intrinsic ability of CD34+ Lin- CDlO’ cells to produce T 
cells was confirmed with highly purified cell populations 
obtained after two consecutive rounds of cell sorting (Ta- 
ble 2, experiment 5), thus eliminating the possible contri- 
Table 2. T Lymphoid Potential of CD34’ Line CDlO’ Cells in the 
SCID-hu Thymus Assay” 
Number of Time of analysis 
Experiment cells post cell injection Engraftment 
number injected (weeks) succes9 
1 9,000 6 213 
2 5,500 6 313 
3 2,000 6 114 
4 2,000 4 414 
2,000 6 414 
5 500 6 213 
a Direct injection of test cells into allogeneic fetal thymic grafts depleted 
of their endogeneous thymocytes. Grafts are subsequently implanted 
under the kidney capsule of SCID mice. 
b Engraftment success is expressed as the fraction of injected grafts 
containing >l% donor-derived T cells over the number of grafts in- 
jected. Altogether, the average percentage of donor-derived T cells 
in grafts reconstituted with CD34’ Lin- CDIO’ cells is 66% f 36% 
(n = 16), and grafts injected with CD34’ Lin- CDlO- cells contain 
74% 2 26% donor-derived T cells (n = 15). 
bution of cells with a different phenotype. Thymic reconsti- 
tution occurred following injection of as little as 500 CD34+ 
Lin- CDlO+ cells or as early as 4 weeks post-cell injection, 
indicating strong T cell potential comparable to that ob- 
served with CD34’ Lin- CD45RA’ cells (Galy et al., 1995). 
We confirmed that T cells derived from the differentiation 
HLA-HOST 
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Figure 1, Representative Example of a Human Thymus Graft Recon- 
stituted with Thymocytes Derived from Microinjection of 9,000 CD34’ 
Line CDlO+ Cells 
Three-color immunostaining (using PE, fluorescein and tricolor- 
conjugated MAbs) was performed on a single cell suspension of the 
human fetal graft retrieved from the SCID mouse 6 weeks after cell 
injection. In this experiment, donor-derived cells are identified by ex- 
pression of monomorphic HLA class I determinants (recognized by the 
W6/32 MAb) but lack of expression of the polymorphic determinants 
specific for the host thymus (HLA-Host). Similar results were obtained 
when donor cells were positively identified with expression of specific 
polymorphic determinants lacking on host cells. Donor-derived T cells 
also express CD45 (data not shown) confirming their human origin. 
Staining for CDla (Coulter, Hialeah, Florida), CD3, CD4, and CD6 
(Becton Dickinson, California) demonstrates that donor-derived thymo- 
cytes recapitulate the full spectrum of thymocyte differentiation. 
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Figure 2. Qualitative Assessment of Time-Dependent Thymocyte Re- 
constitution in the SCID-hu Thymus Assay 
At 4, 6, and 11 weeks post-cell injection of 2,000 CD34+ Lin‘ CDlO’ 
cells (shaded bars) and of 10,000 CD34+ Lin- CDlO- cells(open bars), 
thymocytes were analyzed by three-color immunostaining for the pres- 
ence of donor cells and expression of CDla and CD3. Results are 
expressed as the percent of CDla-positive cells (A) or CDJ-positive 
cells (B) within the donor-derived population * SD (n = 4 grafts at 
each timepoint for each group). 
of CD34’ Lin- CDlO+ cells were phenotypically polyclonal 
(expressing the a8 or the y6 T cell receptor, CD4 or CD8) 
and responded to mitogenic stimulation (data not shown), 
as found with T cells generated in the SCID-hu thymus 
assay by differentiation of other CD34+ cell populations 
(Galy et al., 1994). Thymic reconstitution was qualitatively 
monitored by three-color immunofluorescence over a pe- 
riod of 11 weeks, following injection of an optimally en- 
grafting number of cells (2,000 CD34’ Lin- CDlO’ cells 
per graft and 10,000 CD34’ Lin- CDlO- cells per graft). 
In thymic grafts injected with the CDlO’ subset, ongoing 
thymopoiesis declined between week 8 and week 11 as the 
proportion of donor-derived CD1 a+ thymocytes dropped 
(from 87% f 18% at week 8 to 8% -c 8% at week 11) 
(Figure 2A), while donor cells were brightly CD3’ (Figure 
26). Such CD1 a- CD32+ donor-derived thymocytes were 
either CD4 or CD8 but no longer coexpressed CD4 and 
CD8 (data not shown), which is consistent with their com- 
plete maturation (Galy et al., 1993). In contrast, thymi re- 
constituted with the CDlO-subset showed ongoing thymo- 
poiesis at week 11 post-cell injection (75% + 25% of the 
donor-derived population expressed CDla and 48% f 
12% of the donor-derived cells expressed low to high lev- 
els of CD3) (Figures 2A and 26). These data suggest that 
CD34’ Lit-- CD1 0’ cells have a more limited T cell repopu- 
lation potential than CD34’ Lint CD1 O- cells and thus sup- 
port the concept that CD34’ Lin- CD1 O+ cells are relatively 
less primitive T progenitor cells than those found in the 
CD34+ Lit-r- CDlO- compartment. 
NK Cell Differentiation Potential 
It is broadly accepted that NK cells and T cells might be 
developmentally related but represent two distinct mature 
hematopietic cell lineages (Lanier et al., 1992). Differentia- 
tion of ABM CD34’ Lin- CDlO+ cells into cells with the 
characteristic CD34- CD56+ CD3- cell surface phenotype 
of NK cells was obtained within 1 to 2 weeks of culture 
on the murine bone marrow stromal cell line SyS-1 in the 
presence of interleukin 2 (IL-2) in all experiments per- 
formed (n = 6). The intrinsic NK differentiation potential of 
CD34’ Lin- CDlO+ cells was confirmed with highly purified 
cells obtained after two consecutive rounds of flow cyto- 
metric sorting (same cells as in Table 2, experiment 5). 
No monocyticlmyeloid cells were observed in CD34’ Lin- 
CDlO’ cultures, although such culture conditions support 
the generation of monocyticlmyeloid cells in cultures of 
CD34’ Lin- CDlO- cells (data not shown). The NK cell 
function of CD56+ CD3- cells derived from the differentia- 
tion of CD34’ Lin- CD1 Of cells (Figure 3A) is demonstrated 
by dose-dependent killing of NK-sensitive K562 target 
cells (Figure 38). A higher frequency of NK progenitors 
was observed in CD34+ Lin- CDlO+ cells compared with 
CD34’ Lin- CDlO- cells (respectively 1 of 75 and 1 of 325 
determined by limit dilution analysis of one ABM sample; 
Taswell, 1981) (Figure 3C). Kinetic studies indicated that 
CD56+ CD3- NK cells appeared earlier in cultures initiated 
with CD34+ Lin- CDlO+ cells (phenotypically detectable in 
the culture at day 9) than in cultures of CD34+ Lin- CDlO- 
(phenotypically detectable in the culture at day 16). Thus, 
the CD34+ Lin- CDlO+ ABM compartment represents a 
population of cells with greater ability to commit to the NK 
lineage than CD34+ Lin- CDlO- ABM cells. 
Myeloid and Erythroid Differentiation Potential 
Myeloid and erythroid progenitor cells were virtually non- 
existent in the CD34+ Lin- CDlO+ cell population (Table 
3). Occasional myeloid colony-forming units (CFUs) com- 
posed of large mononuclear cells were observed (2 per 
1000 cells). The presence of such rare colonies due to sort 
contamination of CD34+ Lin- CDlO- cells seems unlikely, 
since erythroid colonies, more abundant in the CD34’ Lin- 
CDlO- cell population, were not detected. Highly purified 
CD34’ Lin- CDlO+ cells obtained after two rounds of flow 
cytometry sorting yielded no such colony formation, even 
after extended periods of culture (3 and 4 weeks). As antici- 
pated, the CD34’ Lin- CD1 O- population tested in parallel 
generated a large number of colonies of either myeloid, 
erythroid, or mixed (erythroid and myeloid) lineages. The 
growth and differentiation of CD34+ Lin- CDlO+ cells were 
also evaluated in stroma-supported bone marrow cultures. 
Sorted cells were cocultivated on murine SyS-1 stromal 
cells in the presence of IL-3, IL-6, and leukemia inhibitory 
factor (LIF), a cytokine combination known to support the 
growth of adult hematopoietic cells (Murray et al., 1995). 
After 3 weeks, CD34’ Lin- CD1 O-cells expanded consider- 
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Figure 3. Phenotypic and Functional Analysis of NK Progeny 
(A) A representative immunostaining analysis of NK cells derived from 
ABM CD34’ Lin CDlO’ cells cultured on stroma plus IL-2. Such NK 
cells express cell surface CD56 (IeulS-PE, Becton Dickinson) but not 
CD3 (leu4-fluorescein isothiocyanate, Becton Dickinson). 
(B) The results of two independent Vr release assays using K562 
target cells (Sanchez et al., 1994) demonstrating the mean dose- 
dependent cytotoxicity ( f SD) of NK cells derived from CD34’ Lin 
CDlO+ ABM cell cultures. Fetal thymocytes cultured in the presence 
of IL-2 and phytohemagglutinin were used as negative controls. 
(C) The results of a limit dilution analysis of ABM CD34’ Lin CD10 
cell subsets cultured on stroma plus IL-2 for 7 weeks. Wells were 
immunostained and scored for the presence of detectable (21% above 
background) CD56 CD3- NK cells. 
ably (174- to 500-fold total cellular expansion) and 30/o- 
18% of CD34’ cells were still present in the culture, indi- 
cating some retention of primitive hematopoietic cells. 
Morphologically heterogeneous populations of myeloid 
cells were observed. The great majority of cultured cells 
(86%-970/o) expressed the myeloid antigen CD33, with 
no detectable CD19’ lymphoid cells at week 3. Longer 
periods of culture are required to observe differentiation 
of HSCs into CD19+ B cells in this system (Murray et al., 
1995; Baum et al., 1992). In contrast, at week 3, CD34’ 
Lin- CDlO+ cells demonstrated a limited proliferative po- 
tential (3- to 42-fold total cellular expansion) and few 
CD34+ cells (0.70/o-3%) were maintained in the culture. 
A preliminary experiment indicated that CD34’ Lin- CD1 0’ 
cells did not provide long-term (8 weeks) hematopoietic 
reconstitution of human bone fragments implanted into 
SCID mice, a property of HSC (Baum et al., 1992; Chen 
et al., 1994). Also, the depletion of CD10 from the CD34+ 
Lin- population did not prevent hematopoietic repopula- 
tion of SCID-hu bones (data not shown). Thus, CD34’ Lin- 
CDlO+ cells are functionally (Murray et al., 1995; Baum 
et al., 1992; Chen et al., 1994) and phenotypically (Baum 
et al., 1992; Lansdorp and Dragowska, 1992; Srour et al., 
1993; Gunji et al., 1993; Terstappen et al., 1991) distinct 
from HSC. 
B Cell Differentiation Potential 
Considerable B lymphoid differentiation was observed in 
IL-3 + IL-6 + LIF-stimulated bone marrow cultures initiated 
with CD34’ Lin- CDlO’cells. After 3 weeks, such cultures 
contained 8%-76% CD1 9’ cells (Table 3) with a low size 
(forward scatter below 500 arbitrary units) (Figure 4C), 
which otherwise lacked CD34 (data not shown), CD33 (Fig- 
ure 48) expressed CD10 (Figure 4F), low levels of CD20 
(Figure 4G), and HLA-DR (Figure 4H). These data confirm 
that CD34’ Lin- CDlO’ ABM cells are capable of serving 
as B cell precursors and indicate that their B cell progenitor 
potential is more immediate than that of their CDlO- coun- 
terpart. 
Table 3. Myeloid, Erythroid, and Lymphoid Progenitor Cells in CD34’ Lin CD10 Cell Subsets (CDlO’ and CDlO-) 
Myelo-Erythroid Clonogenic Progenitorsa 
Bone Marrow Culture Analysisb 
Experiment 
number 
Fold Cellular Expansion Percent CD34’ cells Percent CD33’ cells Percent CD19’ cells 
CDlO’ CDlO- CDlO’ CDIO- CDlO’ CDlO- CDlO’ CDlO- CDlO’ CDlO- 
1 NT NT NT NT NT 2.6 26 96 14 0 
2c 210/o 4915616.6 42 200 3 5 63 97 6 0 
3’ 2/o/o 2917616 16 500 0.7 16.3 16 91 61 0 
46 OIOIO 2213611 24 174 0.2 6.5 55 66 27 0.5 
56 0/010 4914012.5 3.2 203 NT 3 7 93 76 0 
NT, not tested. 
a Results of methylcellulose cultures are expressed as numbers of myeloid (CFU-G, M, and GM)lerythroid (BFU-E and CFU-E)lmultipotent (CFU-mix) 
progenitors per 1000 cells plated. 
D Bone marrow cocultures were established on preformed SyS-1 mouse bone marrow stroma in the presence of IL-3 (10 nglml), IL-6 (10 nglml), 
and LIF (50 nglml). After 3 weeks of culture, all cells were harvested and counted to calculate total cellular expansion. Cells were stained with 
fluorescein- and P&conjugated MAbs and analyzed on a fluorescence-activated cell scanner (Becton Dickinson). Specific cell staining was measured 
in the live cell gate as determined by size, granularity, and propidium iodide exclusion. Results are expressed as percent of positive cells after 
background subtraction (staining with irrelevant mouse IgGl and IgGLa antibodies). 
c CDlO- cells are also CD45RA-, which explains their higher CFU-mix content. 
d CDlO’ cells were highly purified after two consecutive rounds of flow cytometry sorting. Reanalysis of sort purity after the first round was 91% 
and 96% for experiments 4 and 5, respectively. 
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Irrelevant Ig-FITC Control 
Forward Scatter 
CDl9-FITC 
Forward Scatter 
Forward Scatter 
Forward Scatter 
Figure 4. Flow Cytometry Analysis of 3-week- 
old IL-3’ IL-6+ LIF’ Stroma-Supported Cultures 
Seeded with ABM CD34’ Lin CDlO+ Cells 
Dead cells uptaking PI were excluded from the 
analysis. 
(A) shows the negative control background 
staining. 
(B) shows the correlated expression of CD19 
and CD33 on the cultured cells. 
(C) and (D) represent the size and granularity, 
respectively, (forward and side scatter) of 
CD19’ cells and CD33’ cells (gated as shown 
in [B]). 
(E-H) represent the background staining of a 
negative control, CDlO, CD20, and HLA-DR, 
respectively, on small cells (forward scatter be- 
low 500) and large cells (forward scatter above 
500). Horizontal levels of autofluorescence 
have been placed at different levels for small 
and large cells in order to represent better the 
specificity of the staining. 
DC Differentiation Potential 
Larger cells expressing CD33 were always observed in 
IL-3, IL-6, and LIF-supplemented bone marrow cultures, 
even when these cultures were initiated with highly puri- 
fied CD34’ Lin- CDlO+ cells completely devoid of clono- 
genie progenitor cells (Table 3, experiments4 and 5). How- 
ever, in all experiments, the proportion of CD33’cells was 
considerably smaller than in cultures of CD34’ Lin-CDlO- 
cells. The CD33’cells arising from the CD34’ Lin CDlO+ 
cells were large cells (forward scatter above 500 arbitrary 
units) (Figure 4D) lacking CD34 (data not shown), CD19 
(Figure 4B), CDlO, and CD20 (Figures 4F-4G) and with 
high to very high levels of HLA-DR (Figure 4H). Morpho- 
logic inspection of wells showed large cells with long mem- 
brane processes. To explore fully the differentiative poten- 
tial of CD34’ Lin- CD1 0’ cells, liquid cultures were initiated 
with 9 cytokines (IL-l, IL-3, IL-6, IL-7, KL, granulocyte- 
macrophage colony-stimulating factor [GM-CSF], tumor 
necrosis factor [TNF], FLT3IFLKP ligand [FL], and EPO) 
to support the development of a broad spectrum of hema- 
topoietic cells. In such cytokine-supplemented liquid cul- 
tures, CD34’ Lin- CD1 O’cells grew modestly (total cellular 
expansion was 5-l 0 times less than cultures initiated with 
CD34’ Lin- CDlO- cells) and in all cases differentiated 
exclusively into cells with the morphological (Figure 5A) 
and immunophenotypic features (Figures 6B-6D; Table 
4) associated with DCs (Steinman, 1991; Lafontaine et al., 
1992; O’Doherty et al., 1993). Such liquid cultures con- 
tained cells with very high forward and side scatter charac- 
teristics (Figure 6A), where 40%-630/o of the cells ex- 
pressed very high levels of HLA-DR, 23%-420/o of the cells 
had bright expression of CD1 a, and 18%-260/o of the cells 
showed low levels of CD15, while no cell expressed the 
monocyte antigen CD14 as assessed with the MOP9 anti- 
body, which reportedly stains monocytes but not Langher- 
ans/DCs (Goyert et al., 1989). Scatter analysis of cells 
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Figure 5. Photomicrograph (Objective x 100 Oil) of Cells Cultured for 12 days with a Cocktail of 9 Cytokines, Spun on Slides, and Stained with 
Wright-Giemsa 
(A) Culture initiated with CD34’ Lin CDlO’ ABM cells showing the presence of DCs with different morphologies. 
(B) Culture initiated with CD34’ Lin- CDlO- cells from the same ABM sample and under the same conditions, showing the presence of a wide 
variety of hematopoietic lineages. 
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Figure 6. Representative Example of Flow Cytometry and lmmunostaining Analysis of Cultures Initiated with CD34’ Lin CDlO+ ABM Cells and 
CD34’ Lin CDIO- ABM Cells 
(A-D) CD34’ Lin- CDlO+ ABM cells. 
(E-H) CD34’ Lin CDIO- ABM cells. 
Two-color staining was performed (with PE and fluorescein-conjugated MAbs) to identify CDla, HLA-DR, CD14, and CD15 (Becton Dickinson) 
expression on live cells excluding PI. 
expressing high levels of CD1 a and HLA-DR shows very 
high forward and side scatter consistent with large cells 
such as seen in Figure 5A. The variability in size and CD1 a 
expression are consistent with microheterogeneity within 
DC populations (Steinman, 1991; Lafontaine et al., 1992; 
O’Doherty et al., 1993) and may correspond to DC cells 
at various levels of maturation and activation. No cell with 
the morphological characteristics of monocytes, macro- 
phages, or granulocytes were identifiable in cultures initi- 
ated with highly purified (twice sorted) CD34+ Lin- CDlO+ 
cells. One such DC culture, containing only cells with a 
dendritic morphology and no phenotypically detectable 
CD14’ monocyte or CD19’ 8 cell was tested for the ability 
to stimulate allogeneic CD4’T cell proliferation in a mixed 
lymphocyte reaction. After 8 days, irradiated cultured DCs 
had not grown and neither had CD4+ T cells incubated 
alone (from 1 x lo5 T cells per well to 1.20 -c 0.05 x 
lo5 T cells per well). In contrast, T cells stimulated with 
irradiated cultured DC proliferated (from 1 x lo5 T cells 
per well to 2.8 f 0.3 x 1 O5 per well), confirming that these 
CD34’ Lin- CDlO+-derived cells posessed the functional 
characteristics of DCs (Steinman, 1991). In cytokine- 
supplemented liquid cultures, CD34+ Lin- CDlO- cells 
grew strongly (80- to 95fold cellular expansion in 12-l 5 
days) and differentiated into a morphologically heteroge- 
neous mixture of myelocytes, granulocytes, monocytes, 
Table 4. lmmunophenotypic Analysis of Cultures Initiated with CD34’ Lin- CD10 Subsets (CDlO+ and CDlO-) 
Experiment Length of Starting Fold cellular 
HLA-DR CDla CD14 CD15 
number culture in days population expansion Percent MFI Percent MFI Percent MFI Percent MFI 
1 12 CDIO’ 9.5 40 3,770 26 2,067 0 NA 26 120 
CDlO- 95 27 470 2 757 24 5,240 30 297 
2 15 CDIO’ 12 63 3,005 42 2,371 0 NA 18 127 
CDlO- 60 32 017 2 852 20 4,123 20 91 
3 20 CDIO’ NT 55 2,027 23 1,520 0 NA NT NT 
CDlO- NT 51 546 0 NA 19 4,090 NT NT 
NA, not applicable. 
NT, not tested. 
B Liquid cultures were initiated in a cytokine cocktail (17) with CD34’ Lin- CD10 subsets (CDlO+ and CDlO-). After 12-20 days, the cultured cells 
were stained with a direct two-color method using fluorescein, or PE-conjugated MAbs as in Figure 4. Results are expressed as percentage of 
cells positive for the marker (after subtraction of background staining with an IgGl plus IgGPa irrelevant control) and mean fluorescence intensity 
(MFI) of the positive cell population. Analysis was done applying an identical live (propidium iodide-negative) or forward/scatter gate to cultures 
of CDlO+ and CDlO- cells from the same experiment. 
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macrophages, erythroblasts, DCs, and mast cells (see Fig- 
ure 58) with diverse scatter characteristics (Figure 6E). 
These observations confirm that the cytokine-supported 
liquid culture conditions are permissive for the differ- 
entiation of a broad array of cells belonging to multiple 
hematopoietic lineages and underscore the restricted dif- 
ferentiative potential of CD34+ Lin- CDlO+ cells. Immu- 
nophenotypic analysis of CD34’ Lin- CDlO- cultures re- 
vealed that 19%-240/o of the cells expressed high levels 
of CD14, 20%-300/o of the cells expressed CD15 27%- 
51 % of the ceils expressed HLA-DR (albeit at lower levels 
than on cells in cultures of CD34+ Lin- CDlO’ cells), and 
very few (00/o-2%) cells expressed CDla. Morphologic, 
phenotypic and functional data demonstrate that CD34’ 
Lin- CDlO’ ABM cells serve as dendritic cell precursors 
(Steinman, 1991) and have lost the ability to generate my- 
eloid cells such as granulocytes, mast cells, and mono- 
cytes. 
Megakaryocyte Differentiation Potential 
Differentiation of cell populations into the megakaryocytic 
lineage was evaluated in liquid cultures supplemented 
with Mpl-ligand/thrombopoietin and IL-3, both potent in- 
ducers of megakaryocyte development (Kaushansky et 
al., 1994). After 1 week of culture, most CD34’ Lin- CD1 0’ 
cells did not survive (16% viability determined with trypan 
blue exclusion) and did not express CD41, whereas cul- 
tures initiated with CD34’ Lin- CDlO- cells (94% viable 
cells) contained cells having differentiated into CD41’ 
megakaryoblasts (data not shown). In summary, CD34’ 
Lin- CDlO’ cells are not capable of generating erythroid, 
monocytic, granulocytic, and megakaryocytic cells, but 
can differentiate into DCs and all classes of lymphoid cells. 
Multipotential Lymphoid/DC Clones Are Found 
Among CD34”’ Lin- CDlO+ Cells 
The overall lineage potential of the relatively small CD34’ 
Lin- CDlO’ cell subset could reflect the differentiative 
properties of separate phenotypically identical committed 
precursors and could be due to the presence of multipoten- 
tial clones. As shown in Figure 4, IL-3’ IL-6’ LIF+ stroma- 
supported cultures allow CD34’ Lin- CDlO+ progenitor 
cells to differentiate simultaneously into CD1 9+ B cells and 
CD33’ DC and DC precursors. Limiting dilution (LD)exper- 
iments were established to test whether B and DC could 
arise from the differentiation of a single CD34’ Lin- CD1 0’ 
progenitor cell. Based on previous results, we reasoned 
that ABM cells expressing high levels of cell surface CD34 
antigen (greater than lOO-fold that of the isotype control) 
might be more primitive and represent a more homoge- 
neous multipotent progenitor cell population (DiGiusto et 
al., 1994). Indeed, as shown in Figure 7, ABM CD34’ Lin- 
CDlO+ cells can be further segregated into CD34”’ Lin- 
CDlO+ cells and CD34’” Lin- CDlO’ cells. Such CD34h’ 
Lin CDlO+ cells were obtained to a high purity (>96%) 
after two consecutive rounds of flow cytometry sorting. 
Cells were plated at 100, 33, 10, and 3 cells per well by 
LD and cultured for 3 weeks. At the end of culture, all 
wells were microscopically examined, cells harvested by 
repeated pipetting to disrupt and kill the stromal mono- 
Isotype Control 
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Figure 7. Flow Cytometry Sorting of ABM Cells 
(A) Representation of the correlated expression of CD34 and of an 
irrelevant background control PE stain on live (PI-) Lin (CD2, CD14, 
CD16 CD1 9, glycophorin-A)) cells. CD34-, CD34’” and CD34”’ levels, 
respectively, are defined by mean fluorescence intensity (MFI) levels 
of the isotype-matched control for the CD34 antibody, within lo- to 
106fold the MFI of the isotype control, and at levels greater than 
lOO-fold the MFI of the isotype control (DiGiusto et al., 1994). 
(B) The correlated expression of CD34 and CD1 0 on live Lin cells, The 
percentages indicated in each region correspond to the percentage of 
live Lin cells in that region after background subtraction (as deter- 
mined by isotype control values in [A]). 
(C) The ungated reanalysis of twice sorted CD34”’ Lin CDlO’ cells. 
layer. The resulting cell suspension was tested by two- 
color flow cytometry for the presence of live (excluding PI) 
hematopoeitic cells expressing CD19’ (B cells) or CD33’ 
(DC and DC precursors). The maximum likelihood esti- 
mate of clonogenic precursors was 0.1050 (1/g52) with a 
95% confidence interval (1/,28-1/,.58) calculated with the 
single hit Poisson model (Taswell, 1981). A Bayesian prob- 
ability model with uniform prior distribution, better suited 
for the analysis of small data samples (Chick, 1995) gives 
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Figure 8. Flow Cytometry Sorting Analysis of Cells Arising from the LD Analysis 
Pooled cells from wells seeded with 100 CD34”’ Lin CDlO’ ABM cells and cultured for 3 weeks on stroma plus IL-3, IL-6, LIF, IL-7, IL-2, and 
IGF-I, were immunostained with anti-CD58 and anti-CD19 antibodies. CD56’ CD19- cells (a), CD56- CD19- cells (b), CD58- CD19’ cells(c) were 
sorted and cultured shortly (3-4 days) in the presence of IL-2 plus IL-7 (20 and 10 nglml), IL-3 plus IL-6 plus KL plus FL plus TNF plus GM-CSF 
plus IL-1 plus IL-7 (see concentrations in Experimental Procedures for liquid cultures) and IL-7 plus IGF-I (10 nglml), respectively. Short-term 
culture was intended to reveal putative non-DC in the CD56- CD19- population. Cells were spun onto glass slides and stained with Wright-Giemsa. 
All slides were processed in parallel and photographed under identical magnification (100x objective oil). 
a posterior mean 0.1072 (1/932) and 95% credible set 
(I/,, 19-1/731). Thus, there is a very high probability (>95%) 
that wells seeded at 3 cells per well dilution contain the 
progeny of a single clone. Of 17 such wells containing live 
hematopoietic cells, 4 had both CD19’ 6 cells and CD33’ 
DCs, demonstrating that the CD34’ Lin- CDlO+ progenitor 
population contains some bipotential B-IymphoidlDC clones. 
Another LD experiment examined the concomitant gener- 
ation of B cells, DCs, and NK cells from CD34h’ Lin- CDlO’ 
ABM cells plated by LD at 300, 100, 33, 10, 3, and 1 cell 
per well on stroma supplemented with IL-3, IL-6, LIF, IL-2, 
IL-7, and insulin-like growth factor-l (IGF-1). Such condi- 
tions were chosen to favor the growth of lymphoid cells 
in general (Kincade, 1994) and of NK cells in particular. 
After 3 weeks, all wells were examined, cells harvested, 
and stained by two-color immunofluorescence with anti- 
bodies to CD19 and CD56 to identify NK cells (CD56+ 
CD19- cells) and B cells (CD19’ CD56- cells). The nature 
of such NKand B cells was confirmed by carefully analyz- 
ing the composition of wells plated at high cell concentra- 
tions (300 and 100 cells per well). As expected of NK cells 
(Lanier et al., 1992), such CD56+ CD19- cells were also 
CD3- (data not shown) and flow cytometry isolation of 
CD56’ CD19- cells showed medium sized blasts with a 
finely granular acidic cytoplasm (Figure 6a). As expected 
of B cells, CD19’ CD56- cells were also CD33- and flow 
cytometry isolation of CD56+ CD19- cells showed small 
cells with a basophilic cytoplasm (Figure 8~). The CD56- 
CD19- population consisted of medium- to large-sized 
cells. Flow cytometry isolation followed by short-term 
multicytokine-supported culture revealed a homogeneous 
DC population (Figure 8b) with no evidence of monocytic 
or granulocytic cells. The results of the LD analysis are 
shown in Table 5. Statistical and probabilistic analysis re- 
spectivelyshowthe maximum likelihood estimateof clono- 
genie precursors at 0.126 (1/,.9) with a 95% confidence 
interval (‘/99-1/6.6) (Taswell, 1981) and the posterior mean 
at 0.128 (1/7.8) with a 95% credible set (1/9.66-1/6.4) (Chick, 
1995). Thus, there is a very high probability (>95%) that 
wells seeded at the 3 and 1 cell per well dilution contain 
the progeny of a single clone. Under clonal conditions, we 
identified a total of 12 wells (out of 191 plated) containing 
CD1 9+ CD56- B cells together with CD19- CD56’ NK cells 
and CD19- CD56- DC cells. The composition of one such 
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Table 5. Limiting Dilution Analysis for the Production of B cells, NK cells and DCsa 
Number of wells Number of wells with live ___ 
Phenotype of cells in wellsc 
Cells per well plated hematopoietic cells” B only NK only DC only BINK B/DC NWDC BINKIDC 
300 3 3 (100%) 0 0 0 0 0 0 3 
100 12 12 (100%) NTd NT NT NT NT NT NT 
33 46 45 (96%) 0 0 2 1 3 0 39 
10 40 26 (54%) 1 3 7 1 4 3 7 
3 95 34 (36%) 1 2 13 2 4 3 9 
1 96 22 (23%) 0 2 16 0 1 0 3 
a CD34”’ Lin- CDlO+ ABM cells plated by limiting dilution on stroma were cultured with 11-3, IL-6, LIF, IL-2, IL-7, and IGF-1 for 3 weeks. 
b Flow cytometric events satisfying both live and scatter gates described in Experimental Procedures are scored as live hematopoietic cells. Flow 
cytometry was more sensitive than microscopy. All wells scoring positive at the microscope had detectable cells by flow cytometry. The frequency 
of clonogenic precursors is approximately 116. 
c Results are expressed as the number of wells containing live hematopoietic cells with the indicated phenotype. B cells are CD19’ CD56- cells, 
NK cells are CD56’ CD19- cells, and DCs are CD19- CD56- cells. 
d NT, not tested. Wells were pooled for flow cytometry sorting (Figure 6). 
well is shown in Figure 9, confirming the expected scatter 
properties of each cell subset. In addition, 2 wells con- 
tained enough cells to be split at the time of analysis and 
had a BINKIDC phenotype. The remaining cells were cul- 
tured with multiple cytokines, generating DC with clear 
morphological features and expressing high levels of 
HLA-DR and CDla (data not shown). Table 5 also shows 
that bipotential clones were observed in all combinations 
possible and that some wells had only one type of progeny. 
Clearly, wells with only DCs exist but their number might 
be overestimated by inclusion of wells having very rare 
null (CD56- CD1 9) non-DC events. These results are con- 
sistent with the stochastic nature of hematopoietic cell 
differentiation (Ogawa, 1993) but should be interpreted 
with caution, because we cannot ascertain that the system 
is equally favorable to the differentiation and growth of 
each cell type. In addition, the number of wells with DC 
Forward scatter 
Forward scatter r Forward scatter 
Figure 9. lmmunophenotypic and Flow Cytometric Characteristics of 
the Multiple Progeny Derived from a Clone 
Cells were stained with CD56 and CD19. The upper left, lower left and 
lower right panels, respectively, represent the scatter characteristicsof 
CD56’ CDlS- NK cells, CD56- CD19- DCs and CD19’ CD56’ cells. 
only may be overestimated due to a conservative scoring 
of the LD. Indeed, many of these wells represent very rare 
non-DC events, which might be either artefacts, rare stro- 
mal ceils, or possibly cells other than DC, which are not 
supported by the culture condition. However, wells with 
DC only were clearly observed. Our results demonstrate 
that CD34”’ Lin- CDlO+ cells contain multipotent progeni- 
tor cell clones for B, NK, and DC. 
CD34+ Lin- CDlO+ Lymphoid/DC-Restricted 
Progenitors Are Found in Fetal Bone Marrow 
A precursor to T and B cells is found in the adult mouse 
thymus but its phenotypically identical counterpart in the 
fetal thymus seems to lack T cell repopulating ability and 
thus is not functionally equivalent (Antica et al., 1993). 
This prompted us to verify that the population of lymphoid 
and DC progenitors that we describe in adult marrow is 
also present in fetal life. Fetal bone marrow (FBM) samples 
were analyzed and showed the presence of CD34’ Lin- 
CDlO+ progenitor cells representing 2.8% and 9.5%, re- 
spectively, of the CD34’ Lin- FBM cells in two samples 
of 23- and 20-week-old gestational age. Such CD34’ Lin- 
CDlO’ FBM cellsgenerated Tcells in the SCID-hu thymus 
assay, since 4 of 5 grafts injected with 2,500 to 10,000 
cells contained donor-derived T cells, 6 weeks post-cell 
injection. Unlike adult progenitor-reconstituted grafts, fetal 
progenitor-reconstituted thymi contained a large majority 
of mature donor-derived T cells. Greater than 97% of do- 
nor-derived thymocytes displayed high levels of CD3, 
lacked CDla, and either expressed CD4 or CD8 but not 
both. Occasionally, a few donor-derived double-positive 
CD4+CD8+ thymocytes were seen, indicating that donor 
cells had gone through that stage and continued to differ- 
entiate. In contrast, at week 6 post-cell injection, immature 
donor-derived thymocytes predominated in grafts recon- 
stituted with FBM CD34’ Lin- CDlO- cells, resembling 
fresh fetal thymi (Terstappen et al. 1992). The data confirm 
that fetal CD34’ Lin- CDlO+ cells are progenitors for T 
cells and indicate that they may be at a relatively advanced 
stage of commitment (compared with the rest of the CD34’ 
cells), therefore displaying a limited thymocyte-regenera- 
tion potential. The adult CD34+ Lin- CDlO+ subset seems 
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to take longer (8-11 weeks) to exhaust its thymocyte- 
regenerating capacity (see Figures 2A and 28) which may 
be owing to ontogeny-related differences in the prolifera- 
tive potential of the progenitors, as described in another 
system (Lansdorp et al., 1993). In methylcellulose assay, 
FBM CD34+ Lin- CDlO+ cells failed to generate hematopoi- 
etic colonies (no BFU-E, CFU-GM, or CFU-mix with 2,000 
cells examined, as opposed to 58 BFU-E, 18 CFU-GM, 
and 0.5 CFU-mix per 1000 CD34’ Lin- CDlO- FBM cells 
plated). Bone marrow stroma-supported cultures initiated 
with FBM CD34’ Lin- CDlO’ cells in the presence of IL-2 
(as in Figure 3) generated CD3- CD58+ NK cells and CD1 9+ 
B cells but failed to produce CD1 4+ monocytes, in contrast 
with cultures initiated with CD34+ Lin- CD1 O- cells, which 
contained NK, B, and monocytes (data not shown). Liquid 
cultures in the presence of an exhaustive combination of 
cytokines (as in Figure 8) showed that CD34+ Lin- CDlO+ 
FBM cells generated a relatively homogeneous culture of 
cells having the morphology of DCs but did not contain 
myeloid cells or granulocytes. Under the same conditions, 
CD34’ Lin- CDlO- FBM cells generated heterogeneous 
cultures clearly comprising myeloid cells such as mature 
granulocytes (data not shown). In summary, FBM CD34’ 
Lin- CD1 O’cells seem to be relatively advanced progenitor 
cells with the potential to generate all classes of lymphoid 
cells (T, B, and NK cells) and DC, but lacking granulol 
monocytic potential. Thus, a fetal counterpart to the adult 
CD34+ Lin- CDlO+ cell is also found with similar hemato- 
poietic lineage potential. 
Discussion 
A new class of hematopoietic progenitor cells was found 
in adult and fetal bone marrow that is distinct from a stem 
cell and other primitive progenitor cells and has a unique 
differentiation potential restricted to the production of 
lymphoid cells and DCs. This progenitor population as 
defined by its phenotype and overall differentiative proper- 
ties is common to all lymphoid cells (T, B, NK cells) and 
to DCs and contains multipckent progenitor cell clones for 
B, NK, and DCs. The existence of a common precursor 
for lymphoid cells in bone marrow had been suggested 
for years (Gore et al., 1991) but such a cell type had not 
been isolated and its full differentiation potential not 
tested. Indirect evidence that a common lymphoid progen- 
itor cell might exist was provided recently by the study of 
mice mutant for the transcription factor Ikaros, which lack 
T, 8, and NK cells but have normal myelopoiesis and eryth- 
ropoiesis (Georgopoulos et al., 1994). The existence of 
multipotential Band NK-IymphoidlDC clones distinct from 
stem cells implies that oligopotent intermediate differ- 
entiative stages exist between HSCs and committed 
lymphoid cells. Lymphoid commitment can occur by the 
gradual restriction of HSC lineage potential rather than 
direct commitment of HSC into monospecific lymphoid 
stages (reviewed by Ogawa, 1993). We speculate that a 
common clone for all lymphoid cells (T, B, and NK cells) 
and DCs exists and might be found within the CD34’ Lin- 
CDlO+ bone marrow population. Further experiments are 
needed to address this point when multilineage clonal 
assays also permissive for T differentiation are available. 
Although some conditions have been identified to pro- 
duce DCs from CD34+ cells (Caux et al., 1994) the devel- 
opmental pathway and lineage affiliation of DCs has been 
obscure until now. Indeed, DCs have been recognized as 
a cell type functionally distinct from monocyteslmacro- 
phages. This conclusion was based on ontogeny, mor- 
phology, phenotype (Janossy et al., 1986) phagocytic 
activity, antigen-presenting ability, cytokine production 
(Steinman, 1991; Macatoniaetal., 1993),andcellularturn- 
over rates (Kampinga et al., 1990) of DCs versus mono- 
cytelmacrophages. There is indirect evidence linking DCs 
to lymphoid cells, based on the isolation of a common 
murine intrathymic progenitor pool (Ardavin et al., 1993) 
and by the expression of several cell surface antigens 
shared between DCs and B cells or T cells (Winkel et al., 
1994). Evidence for IymphoidlDC progenitor cell clones 
provides the direct evidence that progenitors for DC are 
distinct from progenitors that give rise to erythrocytes, 
megakaryocytes, monocytes, and granulocytes. Thus, our 
results demonstrate that DCs are developmentally more 
closely related to lymphoid cells than to myeloid cells. This 
may have important implications for immunopoiesis, as 
T, B, NK, and DC are collectively critical for the immune 
response. 
Embryologic studies using quail/chick chimeras (Le 
Douarin and Jotereau, 1973) and allogeneic or congeneic 
transplantation studies in mice (Scollay et al., 1986) have 
shown that the thymus gland is colonized by prethymic 
progenitors. Studies utilizing SCID-hu mice have shown 
that the human thymus is generally not self-replenishing 
(Namikawa et al., 1990); therefore, a constant input of 
prethymic progenitors is needed from the fetal liver or bone 
marrow. In the murine thymus, the most immature T cell 
precursor population can also give rise to B, NK, and DCs 
but fails to provide long-term hematopoietic reconstitution 
and to generate myeloid and erythroid cells (Wu et al., 
1991; Ardavin et al., 1993; Matsuzaki et al., 1993). The 
production of T, NK, and DCs by immature CD34+ thymo- 
cytes subsets has been confirmed in human studies as 
well (Sanchez et al., 1994; Marquez et al., 1995). Sanchez 
et al. (1994) described a human intrathymic precursor that, 
unlike our bone marrow population, is a homogenous NK 
progenitor (100% clonogenic) and comprises bipotential 
NKiT precursor clones. It is not known whether such cells 
can also derive B cells, DCs, or myeloid cells. As a whole, 
however, the hematopoietic differentiation potential of 
CD34’ Lin- CDlO’ bone marrow cells matches that re- 
ported for the most immature intrathymic progenitor pool. 
A very small fraction (0.2%) of human CD34’ postnatal 
thymocytes with the equivalent phenotype (CDlO’ Lin- 
[CD2, CD14, CD15, CD19, glycophorin A]-) can be found 
(A. G., unpublished data). It is therefore conceivable that 
for the generation of T cells via a thymic-dependent mech- 
anism, some CD34’ Lin- CDlO+ cells could migrate out 
of bone marrow and serve as prothymocytes. 
Little is known about the stages of development leading 
pluripotent primitive HSCs to commit to the lymphoid lin- 
eage. T cell reconstituting activity is a property of HSCs 
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but is also detected in populations depleted of primitive 
long-term repopulating HSC activity in mice (Spangrude 
et al., 1988; Morrison and Weissman, 1995) and man 
(Baum et al., 1992). We clearly showed that human adult 
bone marrow contains T progenitor cells such as CD34’ 
Lin- Thy-l- CD45RA’ cells that are phenotypically and 
functionally distinct from CD34’ Lin- Thy-l+ CD45RA- 
HSCs (Galy et al., 1995). The data presented in this paper 
further support the notion that several functionally distinct 
stages of T progenitor cells exist. Practically, we now un- 
derstand that T cell-reconstituting activity found in the 
stem cell-depleted CD34+ Thy-l- fraction (Baum et al., 
1992) can be contributed by at least three distinct types 
of CD34’ Lin- Thy-l - progenitor cells at various stages of 
development: CD45RA-cells (Galyet al., 1995) CD45RA’ 
CDlO- cells (obtained by sorting CD34’ Lin- CDlO- cells, 
restaining for CD45RA expression and isolating CD34’ 
Lin- CDlO- CD45RA’ cells in a second sort, unpublished 
data), and CD45RA+ CD1 0’ cells. We observed that T and 
B cell repopulation derived from CD34’ Lin CD1 0’ bone 
marrow cells seemed limited in time and that DCs, B, and 
NK cells were more readily generated by CD34’ Lin- 
CDlO’ ABM cells than by the CDlO- cell subset. This indi- 
cates that CD34+ Lin- CD1 0’ cells are a relatively nonprimi- 
tive population with increased fitness to commit to the DC 
and lymphoid lineages. In vitro, in stroma-supported cul- 
tures, weobserved the differentiation of CD34+Thy-l+ Lin- 
HSCs or of CD34’ Lin- CDlO- CD45RA’ progenitor cells 
into CD34’ Lin- CD1 O+ cells (data not shown). It is therefore 
predictable that B, T, NKcells, or DCs should begenerated 
not exclusively from the CD1 O’subset but may also derive 
from the differentiation of the precursors of CD34’ Lin- 
CDlO’cells. Indeed, CD34’ Lin- CDlO- cells can produce 
B cells in bone marrow cultures after extended periods of 
culture (6-7 weeks) (data not shown) or 8 weeks postinjec- 
tion into SCID-hu bone mice. DCs, T, and NK cells are 
also generated from CD34’ Lin- CDlO- cells, albeit less 
efficiently than from the CD1 O+ subset. This is consistent 
with the notion that CD34+ Lin- CDlO- cells contain primi- 
tive cells that are the upstream precursors of CD34’ Lin- 
CDlO+ cells. Thus, we hypothesize that the early stages 
of lymphopoiesis within the CD34’ Lin- compartment start 
with the progressive differentiation of HSCs into discrete 
progenitor cell stages recognizable by cell surface pheno- 
type. At the functional level, HSC differentiation concurs 
with loss of primitiveness as shown by loss of long-term 
hematopoietic repopulation, with an increasingly restricted 
lineage potential and with greater fitness to commit to the 
lymphoid lineages. Collectively, our current results and 
prior study (Galy et al., 1995) lead us to hypothesize that 
HSC differentiation may progress through a Thy-l- 
CD45RA- stage of multipotent progenitor cells with in- 
creased ability to generate erythroid cells, then via an oli- 
gopotent nonprimitive CD45RA’ stage with myeloid and 
IymphoidlDC potential, followed by a IymphoidlDC-restricted 
CDlO+ progenitor stage before irreversible commitment 
to each lymphoid or DC lineage occurs (Figure 10). Several 
critical points of lineage decision along the pathway of 
HSC development are therefore identified. We postulate 
that lossof Thy-l correlates with lossof primitiveness, that 
acquisition of CD45RAon CD34’ progenitor cells indicates 
a pivotal stage in which the erythroid lineage diverges from 
the myeloid/lymphoid lineages, and that subsequent ac- 
quisition of CD1 0 marksadivergence between the myeloid 
lineages and the IymphoidlDC lineages. These results pro- 
vide a phenotypic and developmental characterization of 
normal human hematopoiesis and are relevant to the 
understanding of the pathophysiology of hematopoiesis 
in general, and lymphopoiesis and immunopoiesis in par- 
ticular. 
Figure 10. Hypothetical Scheme of HSC Dif- 
ferentiation into the Lymphoid and DC Lin- 
eages 
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Experimental Procedures 
Ceil Processing and Staining for immuno-Flow Cytometry 
Adult bone marrow samples were obtained with informed consent from 
normal adult volunteers or from the vertebral bodies of multiorgan 
donors (Northwest Tissue Center, Seattle, Washington). Fetal bone 
marrow samples were obtained from elective abortions with informed 
consent in compliance with state and federal regulations. Mononuclear 
cells (freshly isolated or previously frozen) were incubated with phy- 
coerythrin (PE)-labeled MAbs recognizing CD2, CD4, CDB, CD16, 
CD56, CD19, CD20 (Becton Dickinson, Mountain View, California), 
and glycophorin A (Amac, Westbrook, Maine). Washed cells were incu- 
bated with magnetic beads coated with sheep anti-mouse antibodies 
(Dynal, Oslo, Norway) and bead-bound ceils were removed. Lin- 
depleted ABM cells or CD34+-selected ABM cells, which were obtained 
with a biotin competition system using magnetic bead-bound biotinyl- 
ated anti-CD34 MAbs (K6.1) (Folks et al., 1966). were stained with 
sulphorhodamine-conjugated anti-CD34 MAbs (Tuk3) and fiuores- 
cein-conjugated anti-CD10 (Becton Dickinson) MAbs, washed, resus- 
pended in a propidium iodide (PI) solution (1 pg/ml), before being 
sorted by flow cytometry as described (Galy et al., 1995). 
SCID-hu Thymus Assay 
The assay has been described elsewhere (Galy et al., 1994, 1995). 
Bone Marrow Stroma-Supported Cultures for the Production 
of NK Ceils 
ABM CD34’ Lin- CD1 0 cell subsets were cocuitivated at cell concentra- 
tions ranging from IOO-10,000 cells per well in 96-well plates on pre- 
formed SyS-1 stromal cell monolayers in IMDM (JRH Biosciences, 
Lenexa. Kansas) supplemented with 10% fetal bovine serum (Hyclone, 
Logan, Utah), 5 mglml transferrin, 5 mglml insulin, 5 nglml selenium 
(Sigma, St Louis, Missouri), 50 nglml human recombinant IL-2 (Sandoz 
Pharma, Basel, Switzerland). Plates were incubated in humidified at- 
mosphere at 37% in 5% CO2 and 95% air and medium replaced twice 
a week for up to 7 weeks. 
Measurement of Myeloid and Erythroid Progenitor 
Ceil Content 
Methylcellulose cultures were established in the presence of human 
recombinant IL-3 (10 nglml) (Sandoz Pharma, Basel, Switzerland), 
GM-CSF (25 nglml), granuiocyte CSF (G-CSF) (25 nglml), erythropoie- 
tin (EPO) (1.2 U/ml), and c-kit ligand (KL) (10 nglml) (R and D Systems, 
Minneapolis, Minnesota). Cultures were incubated in humidified atmo- 
sphere at 37OC in 5% COz and 95% air for 2 weeks. 
Liquid Cultures in the Presence of Cytokines 
ABMCD34+Lin-CD10cellsubsets(CD10+andCDlO~)wereincubated 
at 2,000 cells per well in round-bottomed 96well plates in IMDM me- 
dium (same medium employed for NK cultures) supplemented with 
human recombinant IL-3, IL-6, GM-CSF (each at 25 nglml) (Sandoz 
Pharma). IL-7 (10 nglml) (Genzyme, Cambridge, Massachusetts), IL-1 
(5 nglmi), TNF (25 nglml) (Boehringer Mannheim, Indianapolis, Indi- 
ana), EPO (2 U/ml), KL (10 nglml) (R and D Systems), FL (IO nglml) 
(purified after expression in Pichia pastoris [Hannum et al., 19941 and 
provided by the Systemix Core Expression Group). Cultures were incu- 
bated at 37OC in 5% CO? and 95% air and medium was demidepleted 
twice a week. Photographs of cytospins were taken on an Olympus 
BX50 microscope objective x 100 oil. 
Megakaryocyte Cultures 
ABM CD34’ Lin- CD10 cell subsets were cultured for 7 days in the 
presence of purified human recombinant IL-3 (10 rig/ml) and 10% 
supernatant fluid of Cos-7 cells transfected with Mpl ligand cDNA se- 
quences obtained from Bartley et al. (1994) (provided by the Systemix 
Core Expression Group) in IMDM with 5% human plasma. Medium 
was changed twice in 7 days. At the end of culture, viability was mea- 
sured by trypan blue dye exclusion and cells were spun on slides, 
fixed, and CD41 b expression was tested by immunostaining with the 
ED9 Mab provided by R. Ramanathan, Systemix. 
Mixed Lymphocyte Reaction 
CD4+ T cells were obtained by flow cytometry sorting from a culture of 
fetal thymocytes and plated at 1 x lo5 cells per well of a flat-bottomed 
96-well plate (Corning, New York) in IMDM (JRH Biosciences) suppie- 
mented with 10% fetal bovine serum (Hyclone). 5 mglml transferrin. 
5 mglml insulin, 5 nglml selenium (Sigma). Stimulator cells were the 
cells obtained after 3 weeks of culture of CD34’ Lin- CDlO’ ABM cells 
in the presence of IL-3. IL-6. GM-CSF, IL-7, IL-l, TNF, EPO, KL, and 
FL as described above. Stimulator cells were irradiated (3000 rads), 
washed, and 2 x lo4 cells per well were added to the T cells. Results 
are expressed as mean f standard deviation of triplicate wells. 
Limiting Dilution Analysis in Bone Marrow 
Stroma-Supported Cultures 
Flow cytometry-sorted progenitor cells were carefully spun down and 
diluted in medium consisting of 50% IMDM, 50% RPMI, supplemented 
with 10% fetal bovine serum 4 x 1O-5 M P-mercaptoethanol. 10 mM 
HEPES, penicillin (100 U/ml), streptomycin (100 pglml), and 4 mM 
L-glutamine (JRH Biosciences) and cytokines consisting of the follow- 
ing: IL-3 (10 nglml), IL-6 (10 nglml), and LIF (50 nglml) (Sandoz 
Pharma), or IL-3. IL-6, LIF, IL-2 (50 nglml), IL-7, and IGF-1 (both at 20 
nglml, R and D Systems). Cells were distributed in wells onto pre- 
formed Sys-1 bone marrowstromaasdescribed(DiGiustoet al., 1994). 
Cytokine-supplemented medium was changed twice weekly by demi- 
depletion and special care was taken to avoid contamination from 
wells seeded with higher numbers of ceils. At week 3. all wells were 
visually inspected and all wells were subjected to repeated pipetting 
to disrupt and kill the monolayer and to harvest cells, which were 
transferred in microtiter staining plates and costained for CDlS-fluo- 
rescein isothiocyanate and CD33-PE (Becton Dickinson). Negative 
controls include pooled cultured cells and peripheral blood lympho- 
cytesstained with isotype-matched irrelevant antibodies. After staining 
and washes, cells were resuspended in Pi and analyzed on the Fac- 
Scan. The analysis excluded dead cells uptaking PI and excluded 
events falling outside of a wide scatter gate devised to exclude debris 
and noncell events. Only events meeting both criteria were considered 
to be so-called real live cells. A well was scored positive for a phenotypi- 
tally defined population if it contained at least one live cell expressing 
the marker above the level of the isotype control. 
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kines. the Bio-Organic Chemistry and Operations divisions and R. 
Ramanathan for providing MAb reagents, the Flow Cytometry, Com- 
parative Medicine, and Stem Cell Biology Groups for their technical 
support, I. Philip for providing some ABM samples and R. Hoffman, 
I. Weissman. M. Bonyhadi, and N. Uchida for critical review of this 
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